Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Green Dot (GDOT) downgraded to Sell from Neutral at Citi with analyst Andrew Schmidt citing the company's "unexpected" announcement of transitions for its CEO and CFO, which he sees suggesting greater uncertainty. 2. Wells Fargo (WFC) downgraded to Sell from Hold at Odeon Capital with analyst Richard Bove citing his view that "the company appears to be directionless at the moment." 3. Boston Scientific (BSX) downgraded to Buy from Strong Buy at Needham with analyst Mike Matson saying while he sees potential for "modest" revenue and earnings upside in 2020 thanks to the company's strong product cycle, he does not anticipate further revenue growth acceleration beyond high single digits. 4. Colgate-Palmolive (CL) downgraded to Neutral from Buy at BofA/Merrill with analyst Olivia Tong saying while the company has improved its organic sales growth and launched a "meaningful innovation" in its toothpaste and pet categories, she is concerned with its struggles to reverse market share losses in toothpaste as well as the more challenging comps expected in 2020. 5. Choice Hotels (CHH) downgraded to Neutral from Buy at Longbow with analyst Alton Stump citing valuation for the downgrade with the shares up 40% year-to-date and above his prior $96 price target. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage,
click here.